# Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

> **NCT05976932** · — · UNKNOWN · sponsor: **Fudan University** · enrollment: 20 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** pegylated liposomal doxorubicin

## Key facts

- **NCT ID:** NCT05976932
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2024-04
- **Final completion:** 2024-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05976932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05976932, "Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05976932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*